Emerald Acquisition’s Medpace MEDP Stock Holding History

Emerald Acquisition’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$448K	Buy	+15,000	New	+$438K	﹤0.01%	2481

Other funds holding MEDP

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Friess Associates Greenville, Delaware $59.9M AUM 3.42% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

CLM

ClearBridge LLC (Maryland) Baltimore, Maryland $329M AUM 9.73% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Emerald Acquisition's MEDP Position: Q3 2016 in Review

Emerald Acquisition opened a new position in Medpace (MEDP) in Q3 2016: 15,000 shares worth $448K. The stake represents ﹤0.01% of the portfolio and ranks #2481 among its holdings.

67 funds tracked by Wall St. Rank hold MEDP as of Q3 2016.

Emerald Acquisition held 15,000 shares of Medpace worth $448K as of Q3 2016.
Medpace was a new Emerald Acquisition position in Q3 2016.
Medpace made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #2481 holding.
67 funds tracked by Wall St. Rank held Medpace as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.